EPIRUS Biopharmaceuticals, Inc. - FORM 10-Q - EX-10.15 - August 11, 2014

Attached files

file filename
10-Q - FORM 10-Q - EPIRUS Biopharmaceuticals, Inc.d758491d10q.htm
EX-10.12 - EX-10.12 - EPIRUS Biopharmaceuticals, Inc.d758491dex1012.htm
EX-10.13 - EX-10.13 - EPIRUS Biopharmaceuticals, Inc.d758491dex1013.htm
EX-4.3 - EX-4.3 - EPIRUS Biopharmaceuticals, Inc.d758491dex43.htm
EX-10.11 - EX-10.11 - EPIRUS Biopharmaceuticals, Inc.d758491dex1011.htm
EX-4.2 - EX-4.2 - EPIRUS Biopharmaceuticals, Inc.d758491dex42.htm
EX-31.2 - EX-31.2 - EPIRUS Biopharmaceuticals, Inc.d758491dex312.htm
EX-10.14 - EX-10.14 - EPIRUS Biopharmaceuticals, Inc.d758491dex1014.htm
EX-10.2 - EX-10.2 - EPIRUS Biopharmaceuticals, Inc.d758491dex102.htm
EX-4.7 - EX-4.7 - EPIRUS Biopharmaceuticals, Inc.d758491dex47.htm
EX-10.16 - EX-10.16 - EPIRUS Biopharmaceuticals, Inc.d758491dex1016.htm
EX-10.6 - EX-10.6 - EPIRUS Biopharmaceuticals, Inc.d758491dex106.htm
EX-4.4 - EX-4.4 - EPIRUS Biopharmaceuticals, Inc.d758491dex44.htm
EX-31.1 - EX-31.1 - EPIRUS Biopharmaceuticals, Inc.d758491dex311.htm
EX-10.5 - EX-10.5 - EPIRUS Biopharmaceuticals, Inc.d758491dex105.htm
EX-10.8 - EX-10.8 - EPIRUS Biopharmaceuticals, Inc.d758491dex108.htm
EX-4.5 - EX-4.5 - EPIRUS Biopharmaceuticals, Inc.d758491dex45.htm
EX-10.4 - EX-10.4 - EPIRUS Biopharmaceuticals, Inc.d758491dex104.htm
EX-10.3 - EX-10.3 - EPIRUS Biopharmaceuticals, Inc.d758491dex103.htm
EX-10.9 - EX-10.9 - EPIRUS Biopharmaceuticals, Inc.d758491dex109.htm
EX-4.1 - EX-4.1 - EPIRUS Biopharmaceuticals, Inc.d758491dex41.htm
EX-4.6 - EX-4.6 - EPIRUS Biopharmaceuticals, Inc.d758491dex46.htm
EX-32.1 - EX-32.1 - EPIRUS Biopharmaceuticals, Inc.d758491dex321.htm
EX-10.10 - EX-10.10 - EPIRUS Biopharmaceuticals, Inc.d758491dex1010.htm
EXCEL - IDEA: XBRL DOCUMENT - EPIRUS Biopharmaceuticals, Inc.Financial_Report.xls
EX-10.7 - EX-10.7 - EPIRUS Biopharmaceuticals, Inc.d758491dex107.htm

Exhibit 10.15

 

LOGO

Michael Wyand

Dear Michael;

Thank you for your very important contributions to EPIRUS in 2013.

Your new salary for 2014 is $300,000 effective as of April 16, 2014.

Your new 2014 bonus eligibility is 35%.

We look forward to your contributions in 2014 and value you as a member of the EPIRUS team.

Sincerely,

 

/s/ Amit Munshi

Amit Munshi
Chief Executive Officer

 

LOGO

Stock widget

Investing forum

EPIRUS Biopharmaceuticals, Inc. Reports